PL3897694T3 - Hydrolizat kolagenu do stosowania przeciwko atopowemu zapaleniu skóry - Google Patents
Hydrolizat kolagenu do stosowania przeciwko atopowemu zapaleniu skóryInfo
- Publication number
- PL3897694T3 PL3897694T3 PL19835661.0T PL19835661T PL3897694T3 PL 3897694 T3 PL3897694 T3 PL 3897694T3 PL 19835661 T PL19835661 T PL 19835661T PL 3897694 T3 PL3897694 T3 PL 3897694T3
- Authority
- PL
- Poland
- Prior art keywords
- atopic dermatitis
- use against
- collagen hydrolyzate
- against atopic
- hydrolyzate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Rheumatology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102018133374.9A DE102018133374A1 (de) | 2018-12-21 | 2018-12-21 | Kollagenhydrolysat zur Verwendung gegen Hautkrankheiten und Darmkrankheiten |
| PCT/EP2019/086839 WO2020128070A2 (de) | 2018-12-21 | 2019-12-20 | Kollagenhydrolysat zur verwendung gegen hautkrankheiten und darmkrankheiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3897694T3 true PL3897694T3 (pl) | 2025-07-07 |
Family
ID=69159741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19835661.0T PL3897694T3 (pl) | 2018-12-21 | 2019-12-20 | Hydrolizat kolagenu do stosowania przeciwko atopowemu zapaleniu skóry |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12138297B2 (pl) |
| EP (1) | EP3897694B1 (pl) |
| JP (1) | JP7717609B2 (pl) |
| KR (1) | KR20210106443A (pl) |
| CN (1) | CN113271961A (pl) |
| AU (1) | AU2019410881B2 (pl) |
| BR (1) | BR112021010046A2 (pl) |
| CA (1) | CA3122046A1 (pl) |
| DE (1) | DE102018133374A1 (pl) |
| EA (1) | EA202191686A1 (pl) |
| ES (1) | ES3033462T3 (pl) |
| MX (1) | MX2021007486A (pl) |
| PL (1) | PL3897694T3 (pl) |
| WO (1) | WO2020128070A2 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102020126594A1 (de) * | 2020-10-09 | 2022-04-14 | Gelita Ag | Kollagenhydrolysat als Wirkstoff zum Verzögern der Alterung |
| DE102021214899A1 (de) | 2021-12-22 | 2023-06-22 | Gelita Ag | Typ I-Kollagenpeptid zur therapeutischen Verwendung |
| WO2023213909A1 (en) | 2022-05-04 | 2023-11-09 | Rousselot Bv | Collagen hydrolysate composition for reducing joint pain after exercise |
| US20260027188A1 (en) * | 2022-07-29 | 2026-01-29 | Lonza Greenwood Llc | Method and Composition for Treating Conditions Associated with a Leaky Gut Barrier |
| JP7631623B2 (ja) | 2022-08-31 | 2025-02-18 | ルースロ ビーヴイ | 集中治療後症候群(pics)の予防及び/又は治療に使用するためのコラーゲン加水分解物 |
| IT202200022392A1 (it) | 2022-10-31 | 2024-05-01 | Uriach Consumer Healthcare S L | Collagene idrolizzato, processo per la sua preparazione e suoi usi |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO115690B1 (ro) * | 1998-06-17 | 2000-05-30 | Institutul Naţional De Cercetare - Dezvoltare Pentru Ştiinţe Biologice | Unguent antiacneic şi antiseboreic |
| RO115691B1 (ro) * | 1998-06-17 | 2000-05-30 | Institutul Naţional De Cercetare - Dezvoltare Pentru Ştiinţe Biologice | Unguent antipsoriazis |
| HK1040629B (en) * | 1998-12-23 | 2005-01-28 | Idea Ag | Improved formulations for local non-diffusive administration in vivo |
| DE10058772A1 (de) * | 2000-11-27 | 2002-06-06 | Falk Pharma Gmbh | Verfahren zur Herstellung leicht löslicher Arzneimittelformulierungen und entsprechende Formulierungen |
| JP2011111434A (ja) | 2009-11-30 | 2011-06-09 | Obihiro Univ Of Agriculture & Veterinary Medicine | 皮膚機能改善剤及びそれを含む飲食品 |
| CN102652021A (zh) | 2009-12-10 | 2012-08-29 | 罗蒂株式会社 | 特应性皮炎预防剂 |
| DE102010060564A1 (de) * | 2010-11-15 | 2012-05-16 | Gelita Ag | Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel |
| ES2492672T3 (es) * | 2010-12-02 | 2014-09-10 | Medskin Solutions Dr. Suwelack Ag | Colágeno para su uso en el tratamiento de enfermedades cutáneas |
| AU2012344135B2 (en) * | 2011-11-29 | 2017-01-05 | Gelita Ag | Collagen hydrolysate and use thereof |
| DE102012101911A1 (de) * | 2012-03-07 | 2013-09-12 | Gelita Ag | Verwendung von Kollagenhydrolysat |
| US20160082087A1 (en) | 2013-04-26 | 2016-03-24 | Nitta Gelatin Inc. | Whitening promoting agent or atopic dermatitis ameliorating agent |
| CN104382943A (zh) * | 2014-10-20 | 2015-03-04 | 广西壮族自治区花红药业股份有限公司 | 鱼鳞提取物在制备治疗和/或预防银屑病药物方面的新用途 |
| WO2019224035A1 (en) * | 2018-05-24 | 2019-11-28 | Almirall, S.A. | Topical pharmaceutical compositions comprising a corticosteroid |
| DE102019202606A1 (de) * | 2018-11-06 | 2020-05-07 | Gelita Ag | Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung |
-
2018
- 2018-12-21 DE DE102018133374.9A patent/DE102018133374A1/de active Pending
-
2019
- 2019-12-20 EA EA202191686A patent/EA202191686A1/ru unknown
- 2019-12-20 CA CA3122046A patent/CA3122046A1/en active Pending
- 2019-12-20 BR BR112021010046-6A patent/BR112021010046A2/pt unknown
- 2019-12-20 JP JP2021535213A patent/JP7717609B2/ja active Active
- 2019-12-20 ES ES19835661T patent/ES3033462T3/es active Active
- 2019-12-20 CN CN201980083867.9A patent/CN113271961A/zh active Pending
- 2019-12-20 AU AU2019410881A patent/AU2019410881B2/en active Active
- 2019-12-20 MX MX2021007486A patent/MX2021007486A/es unknown
- 2019-12-20 PL PL19835661.0T patent/PL3897694T3/pl unknown
- 2019-12-20 KR KR1020217018852A patent/KR20210106443A/ko active Pending
- 2019-12-20 WO PCT/EP2019/086839 patent/WO2020128070A2/de not_active Ceased
- 2019-12-20 EP EP19835661.0A patent/EP3897694B1/de active Active
-
2021
- 2021-06-17 US US17/350,280 patent/US12138297B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX2021007486A (es) | 2021-08-05 |
| ES3033462T3 (en) | 2025-08-04 |
| EP3897694A2 (de) | 2021-10-27 |
| EA202191686A1 (ru) | 2021-11-08 |
| DE102018133374A1 (de) | 2020-06-25 |
| CN113271961A (zh) | 2021-08-17 |
| AU2019410881A1 (en) | 2021-06-10 |
| AU2019410881B2 (en) | 2025-07-10 |
| CA3122046A1 (en) | 2020-06-25 |
| EP3897694B1 (de) | 2025-04-23 |
| WO2020128070A2 (de) | 2020-06-25 |
| KR20210106443A (ko) | 2021-08-30 |
| JP2022515392A (ja) | 2022-02-18 |
| US20210308231A1 (en) | 2021-10-07 |
| WO2020128070A3 (de) | 2020-08-13 |
| BR112021010046A2 (pt) | 2021-08-17 |
| JP7717609B2 (ja) | 2025-08-04 |
| US12138297B2 (en) | 2024-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3897694T3 (pl) | Hydrolizat kolagenu do stosowania przeciwko atopowemu zapaleniu skóry | |
| IL261627B (en) | A method and system for optimizing and predicting demand response | |
| PL3592037T3 (pl) | Sposób i urządzenie do przełączania | |
| IL255002B (en) | Annuloplasty technologies | |
| EP3626699A4 (en) | SSAO INHIBITOR | |
| PL3523053T3 (pl) | Urządzenie do powlekania i przynależny sposób eksploatacji | |
| EP3590577A4 (en) | OBJECT TRACKING DEVICE | |
| EP3571840A4 (en) | RATE CONTROL | |
| EP3725246C0 (en) | MENISCUS REPAIR DEVICES, SYSTEMS AND METHODS | |
| DK3589151T3 (da) | Rullebaseret lukkesystem | |
| EP3565081A4 (en) | ELECTRICAL SUPPLY SYSTEM | |
| PL3305035T3 (pl) | Sposób i system do sterowania włączaniem świateł | |
| EP3570139A4 (en) | CONTROL DEVICE | |
| DE112018006483A5 (de) | Elektrochemisches System | |
| DK3532772T3 (da) | Strømforsyningssystem. | |
| EP3795412A4 (en) | POWER SYSTEM | |
| DK3649164T3 (da) | Modificerede polymerpolyoler | |
| EP3614216A4 (en) | CONTROL UNIT | |
| PL3018979T3 (pl) | Sposób działania i rozbudowy sieci oświetleniowej | |
| EP3418851C0 (en) | CONTROL BODY | |
| BR112017027497A2 (pt) | Abastecimento de água para um animal | |
| DK3592297T3 (da) | Vævsteknologistilladser | |
| IL250618A0 (en) | Motor control system and method | |
| EP3653868A4 (en) | HYDROELECTRIC SYSTEM | |
| EP3449805A4 (en) | Resectoscope |